WallStreetZen

NYSE: JNJ
Johnson & Johnson Stock Forecast, Predictions & Price Target

Analyst price target for JNJ

Based on 12 analysts offering 12 month price targets for Johnson & Johnson.
Min Forecast
$155.00-3.31%
Avg Forecast
$168.92+5.37%
Max Forecast
$182.00+13.54%

Should I buy or sell JNJ stock?

Strong Buy
Strong Buy
8 analysts 66.67%
Buy
1 analysts 8.33%
Hold
3 analysts 25%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Forecast return on equity

Is JNJ forecast to generate an efficient return?
Company
43.86%
Industry
74.22%
Market
62.25%
JNJ's Return on Equity is forecast to be high in 4 years (43.86%); analysts are confident in the firm's ability to efficiently generate return on equity
Forecast

Forecast return on assets

Is JNJ forecast to generate an efficient return on assets?
Company
16.57%
Industry
16.87%
Market
19.66%
JNJ is forecast to generate lower Return on Assets (16.57%) than the US Drug Manufacturers - General industry average (16.87%)
Forecast

JNJ earnings per share forecast

What is JNJ's earnings per share in the next 3 years based on estimates from 9 analysts?
Avg 1 year Forecast
$8.89+37.57%
Avg 2 year Forecast
$9.74+50.83%
Avg 3 year Forecast
$10.51+62.62%
JNJ's earnings are forecast to grow at a rate of 17.73% per year, which is not exceptional
Forecast

JNJ revenue forecast

What is JNJ's revenue in the next 3 years based on estimates from 5 analysts?
Avg 1 year Forecast
$88.5B+9.51%
Avg 2 year Forecast
$93.0B+15.05%
Avg 3 year Forecast
$98.4B+21.71%
JNJ's revenue is forecast to grow at a rate of 6.66% per year, which is not exceptional
Forecast

JNJ earnings growth forecast

How is JNJ forecast to perform vs Drug Manufacturers - General companies and vs the US market?
Company
17.73%
Industry
24.82%
Market
20.47%
JNJ's earnings are forecast to grow slower (17.73% per year) than the US Drug Manufacturers - General industry average (24.82%)
Forecast
JNJ's earnings are forecast to grow slower (17.73% per year) than the US market average (20.47%)
Forecast
JNJ's earnings are forecast to grow faster (17.73% per year) than the risk-free savings rate (1.1%)
Forecast

JNJ revenue growth forecast

How is JNJ forecast to perform vs Drug Manufacturers - General companies and vs the US market?
Company
6.66%
Industry
6.43%
Market
14.48%
JNJ's revenues are forecast to grow faster (6.66% per year) than the US Drug Manufacturers - General industry average (6.43%)
Forecast
JNJ's revenues are forecast to grow slower (6.66% per year) than the US market average (14.48%)
Forecast

Johnson & Johnson Stock Forecast FAQ

Is Johnson & Johnson Stock a good buy in 2020, according to Wall Street analysts?

The consensus among 12 Wall Street analysts covering (NYSE: JNJ) stock is to Strong Buy JNJ stock.

Out of 12 analysts, 8 (66.67%) are recommending JNJ as a Strong Buy, 1 (8.33%) are recommending JNJ as a Buy, 3 (25%) are recommending JNJ as a Hold, 0 (0%) are recommending JNJ as a Sell, and 0 (0%) are recommending JNJ as a Strong Sell.

What is JNJ's Price Target?

According to 12 Wall Street analysts that have issued a 1 year JNJ price target, the average JNJ price target is $168.92, with the highest JNJ stock price forecast at $182.00 and the lowest JNJ stock price forecast at $155.00.

On average, Wall Street analysts predict that Johnson & Johnson's share price could reach $168.92 by Jan 8, 2022. The average Johnson & Johnson stock price prediction forecasts a potential upside of 5.37% from the current JNJ share price of $160.30.

What is JNJ's earnings growth forecast for 2021-2023?

(NYSE: JNJ) Johnson & Johnson's forecast annual earnings growth rate of 17.73% is not forecast to beat the US Drug Manufacturers - General industry's average forecast earnings growth rate of 24.82%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 20.47%.

Johnson & Johnson's earnings in 2020 is $16,986,000,000.On average, 9 Wall Street analysts forecast JNJ's earnings for 2021 to be $23,397,112,375, with the lowest JNJ earnings forecast at $23,089,861,876, and the highest JNJ earnings forecast at $23,827,052,449. On average, 6 Wall Street analysts forecast JNJ's earnings for 2022 to be $25,652,388,964, with the lowest JNJ earnings forecast at $24,616,899,491, and the highest JNJ earnings forecast at $26,459,875,924.

In 2023, JNJ is forecast to generate $27,657,810,605 in earnings, with the lowest earnings forecast at $26,538,860,628 and the highest earnings forecast at $28,776,760,582.

What is JNJ's revenue growth forecast for 2021-2023?

(NYSE: JNJ) Johnson & Johnson's forecast annual revenue growth rate of 6.66% is forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 6.43%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.48%.

Johnson & Johnson's revenue in 2020 is $80,856,000,000.On average, 5 Wall Street analysts forecast JNJ's revenue for 2021 to be $233,129,146,805,520, with the lowest JNJ revenue forecast at $230,566,882,999,650, and the highest JNJ revenue forecast at $235,645,599,482,925. On average, 5 Wall Street analysts forecast JNJ's revenue for 2022 to be $244,917,608,649,186, with the lowest JNJ revenue forecast at $241,037,621,959,725, and the highest JNJ revenue forecast at $248,156,776,636,125.

In 2023, JNJ is forecast to generate $259,097,474,586,488 in revenue, with the lowest revenue forecast at $255,902,543,299,575 and the highest revenue forecast at $262,292,405,873,400.

What is JNJ's Earnings Per Share (EPS) forecast for 2021-2023?

(NYSE: JNJ) Johnson & Johnson's current Earnings Per Share (EPS) is $6.46. On average, analysts forecast that JNJ's EPS will be $8.89 for 2021, with the lowest EPS forecast at $8.77, and the highest EPS forecast at $9.05. On average, analysts forecast that JNJ's EPS will be $9.74 for 2022, with the lowest EPS forecast at $9.35, and the highest EPS forecast at $10.05. In 2023, JNJ's EPS is forecast to hit $10.51 (min: $10.08, max: $10.93).

What is JNJ's forecast return on equity (ROE) for 2021-2024?

(NYSE: JNJ) forecast ROE is 43.86%, which is considered strong.

What is JNJ's forecast return on assets (ROA) for 2021-2024?

(NYSE: JNJ) forecast ROA is 16.57%, which is lower than the forecast US Drug Manufacturers - General industry average of 16.87%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Heap | Mobile and Web Analytics